[2006] 1.4 Personalised package of care and information 1.4.1 Offer people with atrial fibrillation a personalised package of care. Ensure that the package of care is documented and delivered, and that it covers: stroke awareness and measures to prevent stroke rate control assessment of symptoms for rhythm control who to contact for advice if needed psychological support if needed up-to-date and comprehensive education and information on: cause, effects and possible complications of atrial fibrillation management of rate and rhythm control anticoagulation practical advice on anticoagulation in line with the recommendations on information and support for people having anticoagulation treatment in NICE's guideline on venous thromboembolic diseases support networks (for example, cardiovascular charities). [2014] 1.4.2 Follow the recommendations in NICE's guideline on shared decision Medicines adherences and optimisation 1.4.3 To support adherence and ensure safe and effective medicines use in people with atrial fibrillation, follow the recommendations in NICE's guidelines on medicines adherence and medicines optimisation. [2021] 1.5 Referral for specialised management 1.5.1 Refer people promptly at any stage if treatment fails to control the symptoms of atrial fibrillation and more specialised management is needed. This should be within 4 weeks after the failed treatment or after recurrence of atrial fibrillation after cardioversion. [2014] 1.6 Stroke prevention Anticoagulation 1.6.1 When discussing the benefits and risks of anticoagulation use clinical risk profiles and personal preferences to guide treatment choices. Discuss with the person that: for most people the benefit of anticoagulation outweighs the bleeding risk for people with an increased risk of bleeding, the benefit of anticoagulation may not always outweigh the bleeding risk, and careful monitoring of bleeding risk is important. 